Structural investigations of a new familial dysalbuminemic hyperthyroxinemia genotype

Clinical Chemistry

Volumn 45, Issue 8 I, 1999, Pages 1248-1254

  Petersen, Charles E ^a   Ha, Chung Eun ^a   Harohalli, Krishna ^a   Park, David S ^a   Feix, Jimmy B ^b   Isozaki, Osamu ^c   Bhagavan, Nadhipuram V ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN SERUM ALBUMIN;

ALBUMIN BLOOD LEVEL; AMINO ACID SUBSTITUTION; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; DNA SEQUENCE; FAMILIAL DISEASE; GENOTYPE; HORMONE DETERMINATION; HUMAN; HYPERTHYROXINEMIA; PATHOGENESIS; SPECTROFLUOROMETRY;

EID: 0032878898     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.8.1248     Document Type: Article

References (26)

1. Ruiz M, Rajatavan RA, Taylor C, Brown R, Braverman LE, Ingbar SH. Familial dysalbuminemic hyperthyroxinemia: a syndrome that can be confused with thyrotoxicosis. N Engl J Med 1984;306: 635-9.
2. Lee WNP, Golden MP, Van Herlem AJ, Lippe BM, Kaplan SA. Inherited abnormal thyroid hormone-binding protein causing selective increase of total serum thyroxine. J Clin Endocrinol Metab 1979;49:292-9.
3. Stockight JR, Topliss DJ, Barlow JW, White EL, Hurley DM, Taft P. Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albumin. J Clin Endocrinol Metab 1981;53:353-9.
4. Docter R, Bos G, Krenning EP, Fekkes D, Visser TJ, Hennemann G. Inherited thyroxine excess: a serum abnormality due to an increased affinity for modified albumin. Clin Endocrinol 1981;15: 363-71.
5. Borst GD, Premachandra BN, Burman KD, Osborne RC, Georges LP, Johnsonbaugh RE. Euthyroid familial hyperthyroxinemia due to abnormal thyroid hormone binding protein. Am J Med 1982;73: 283-9.
6. 4 by an inherited albumin variant. Clin Endocrinol 1983;18:11-4.
7. Barlow JW, Csicsmann JM, White EL, Funder, JW, Stockigt JR. Familial euthyroid thyroxine excess: characterization of abnormal intermediate affinity thyroxine binding to albumin. J Clin Endocrinol Metab 1982;55:244-50.
8. Petersen CE, Scottolini AG, Cody LR, Mandel M, Riemer, N. Bhagavan NV. A point mutation in the human serum albumin gene results in familial dysalbuminemic hyperthyroxinemia. J Med Genet 1994;31:355-9.
9. Sunthornthepvarakul T, Angekeow P, Weis RE, Hayashi Y, Refetoff S. An identical missense mutation in the albumin gene results in familial dysalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun 1994;202:781-7.
10. Rushbrook JI, Becker E, Schussler GC, Divino CM. Identification of a human serum albumin species associated with familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab 1995;80: 461-7.
11. Scottolini AG, Bhagavan NV, Oshiro T, Powers L. Familial dysalbuminemic hyperthyroxinemia: a study of four probands and a kindred of three. Clin Chem 1984;30:1179-81.
12. Arevalo G. Prevalence of familial dysalbuminemic hyperthyroxinemia in serum samples received for thyroid testing. Clin Chem 1991;37:1430-1.
13. Wada N, Chiba H, Shimizu C, Kijima H, Kubo M, Koike T. A novel missense mutation in codon 218 of the albumin gene in a distinct phenotype of the familial dysalbuminemic hyperthyroxinemia in a Japanese kindred. J Clin Endocrinol Metab 1997;82:3246-50.
14. Petersen CE, Ha C-E, Mandel M, Bhagavan NV. Expression of a human serum albumin variant with high affinity for thyroxine. Biochem Biophys Res Commun 1995;214:1121-9.
15. Glatz JFC, Veerkamp JH. Removal of fatty acids from serum albumin by Lipidex 1000. J Biophys Methods 1983;8:57-61.
16. Dughi C, Bhagavan NV, Jameson DM. Fluorescence investigations of albumin from patients with familial dysalbuminemic hyperthyroxinemia. Photochem Photobiol 1993;57:416-9.
17. Tokuoka R, Okabe N, Tomita K. Circular dichroism studies on the interaction between human serum albumin and thyroxine. J Biochem (Tokyo) 1980;87:1729-34.
18. Okabe N, Manabe N, Tokuoka R, Tomita K. Interaction of diiodo-i-tyrosine and triiodophenol with bovine serum albumin. Circular dichroism and fluorescence studies. J Biochem (Tokyo) 1976;80: 455-61.
19. Petersen CE, Ha C-E, Jameson DM, Nadhipuram NV. Mutations in a specific human serum albumin thyroxine binding site define the structural basis of familial dysalbuminemic hyperthyroxinemia. J Biol Chem 1996;271:19110-7.
20. Steiner RF, Roth J, Robbins J. The binding of thyroxine by serum albumin as measured by fluorescence quenching. J Biol Chem 1966;241:560-7.
21. 125I-labeled p-iodobenzoate to human serum albumin: interaction with the primary thyroxine binding site. Arch Biochem Biophys 1979;198:403-5.
22. Sterling K. Molecular structure of thyroxine in relation to its binding in human serum albumin. J Clin Investig 1964;43:1721-9.
23. Tabachnick M. Binding of thyroxine to human serum albumin and modified albumins. J Biol Chem 1964;239:1242-9.
24. Kamikubo K, Sakata S, Kakamura S, Komaki T, Miura K. Thyroxine binding to human serum albumin immobilized on Sepharose and effects of nonprotein albumin-binding plasma constituents J Protein Chem 1990;9:461-5.
25. Petersen CE, Ha C-E, Harohalli K, Park D, Bhagavan NV. Mutagenesis studies of thyroxine binding to human serum albumin define an important structural characteristics of subdomain 2A. Biochemistry 1997;36:7012-7.
26. Carter DC, Ho JX. Structure of serum albumin. Adv Protein Chem 1994;45:153-203.